Distribution agreement for laboratory chemicals
Covidien has announced that its Mallinckrodt Baker business unit has entered into a multi-year agreement with global laboratory supply company, VWR International to distribute Mallinckrodt Baker?s J.T.Baker brand products in Eastern and Central Europe.
Covidien has announced that its Mallinckrodt Baker business unit has entered into a multi-year agreement with global laboratory supply company, VWR International to distribute Mallinckrodt Baker’s J.T.Baker brand products in Eastern and Central Europe.
The company offers products ranging from solid-phase extraction materials for chromatography to liquid chromatography solvents and traditional laboratory chemicals such as salts, acids and buffers.
“Combining Mallinckrodt Baker’s strong product offering with VWR’s distribution base and existing infrastructure in Europe allows both companies to enhance their presence in this key region,” said Peter Krabbenborg, analytical business manager, Mallinckrodt Baker Europe. “We anticipate strong growth and development in pharmaceuticals and research biochemicals in many Eastern and Central European countries over the next several years, and we’re excited about the synergies that will be gained from our new agreement with VWR and the opportunity to better serve the needs of this rapidly growing market.”
For more information visit www.mallbaker.com
RAFA 2024: Giorgia Purcaro on Multidimensional GC for Mineral Oil Hydrocarbon Analysis
November 27th 2024Giorgia Purcaro from the University of Liège was interviewed at RAFA 2024 by LCGC International on the benefits of modern multidimensional GC methods to analyze mineral oil aromatic hydrocarbons (MOAH) and mineral oil saturated hydrocarbons (MOSH).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Identifying Antioxidative Properties in Berries with UHPLC-MS
Published: November 27th 2024 | Updated: November 27th 2024A recent study identified and quantified anthocyanin (which are known for their antioxidative properties and potential effectiveness against depression) in blueberries, blackberries, black mulberries, and cranberries using ultra high-pressure liquid chromatography (UHPLC) followed by in vivo evaluation of their antidepressant-like activities.
In Conversation with the EAS Award Winner for Outstanding Achievements in Mass Spectrometry
November 27th 2024As part of our EAS 2024 coverage, we recently interviewed Benjamin Garcia of the Washington University in St. Louis about his work and his being awarded the EAS Award for Outstanding Achievements in Mass Spectrometry.
